Case Western Reserve University named International Center of Excellence for Malaria Research

July 12, 2010

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) has named Case Western Reserve University School of Medicine as the lead institution of an International Center of Excellence for Malaria Research (ICEMR). The $7.9M seven-year grant will accelerate the control of malaria and help eliminate it worldwide. The prestigious center is one of ten new malaria research centers around the world. James Kazura, MD, Professor of International Health and Medicine at Case Western Reserve University will serve as the principle investigator of a project titled "Research to Control and Eliminate Malaria in SE Asia and SW Pacific."

The NIAID awards will establish ICEMRs in regions where malaria is endemic, including parts of Africa, Asia, the Pacific Islands and Latin America. The objective of the "Research to Control and Eliminate Malaria in SE Asia and SW Pacific" project is to advance knowledge of how national and regional programs to control and eliminate malaria in Papua New Guinea and Solomon Islands affect the disease's epidemiology, transmission by the essential mosquito vectors, pathogenesis, and morbidity. Papua New Guinea and Solomon Islands represent a wide spectrum of malaria transmission intensity and disease, as all four types of human malaria exist in mosquitoes and humans who are exposed to these insect vectors that transmit the parasite. The ICEMR at Case Western Reserve University will integrate clinical and field approaches with laboratory-based immunologic, molecular and genomic methods and concepts. Like the other ICEMRs, the research will investigate the transmission of malaria by mosquitoes and the pathogenesis of the disease it causes in infected humans. Research findings will be compiled and shared among centers in order to advance the development of long-term sustainable tools for eliminating and eradicating malaria globally through the development of safer, more effective drugs and ultimately, the creation of a vaccine to stop the transmission of the disease.

The ICEMR at Case Western Reserve University will oversee a collaborative research team of internationally respected investigators from the Papua New Guinea Institute of Medical Research, Walter & Eliza Hall Institute of Medical Research, University of Queensland, Centers for Disease Control and Prevention - Division of Parasitic Diseases, Swiss Tropical Institute, the Burnet Institute of Melbourne, the University of Melbourne, and the Vector Borne Disease Control Programme in the Solomon Islands. Research conducted in Papua New Guinea will build on more than 20 years of a successful work and collaboration by Dr. Kazura and his peers at Case Western Reserve, Australian and Papua New Guinean institutions. The Solomon Islands initiative is a new research project.

"Case Western Reserve University is honored to be among the elite group of ICEMRs who share a common vision of reducing the health burden of malaria in the world. Our participation and leadership is a demonstration of our substantive work which is poised to make a marked difference in malaria control and global eradication of the disease," says Dr. Kazura, director of the university's Center for Global Health and Diseases. "This is an unprecedented project and opportunity; the ICEMR program offers incredible promise by its emphasis on a targeted research approach that involves the use of best practices and similar research protocols across various malaria endemic areas. Ultimately, this globally coordinated program represents a concerted effort to first limit the health burden of malaria and second, to irrevocably stop its transmission in Asia, Africa, Latin America, and Pacific nations where the disease continues to have its major impact on infants, children, and pregnant women."

Malaria, one of the world's "big three" diseases, along with tuberculosis and HIV/AIDS, has been eliminated from many parts of the globe, but 40 percent of the world's population still live in areas where they are at risk for contracting the disease. Infection by malaria-causing parasites results in approximately 240 million cases around the globe annually, and causes more than 850,000 deaths each year.
-end-
About Case Western Reserve University School of Medicine

Founded in 1843, Case Western Reserve University School of Medicine is the largest medical research institution in Ohio and is among the nation's top medical schools for research funding from the National Institutes of Health. The School of Medicine is recognized throughout the international medical community for outstanding achievements in teaching. The School's innovative and pioneering Western Reserve2 curriculum interweaves four themes--research and scholarship, clinical mastery, leadership, and civic professionalism--to prepare students for the practice of evidence-based medicine in the rapidly changing health care environment of the 21st century. Nine Nobel Laureates have been affiliated with the school of medicine.

Annually, the School of Medicine trains more than 800 MD and MD/PhD students and ranks in the top 20 among U.S. research-oriented medical schools as designated by U.S. News & World Report "Guide to Graduate Education."

The School of Medicine's primary affiliate is University Hospitals Case Medical Center and is additionally affiliated with MetroHealth Medical Center, the Louis Stokes Cleveland Department of Veterans Affairs Medical Center, and the Cleveland Clinic, with which it established the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University in 2002. http://casemed.case.edu.

Case Western Reserve University

Related Malaria Articles from Brightsurf:

Clocking in with malaria parasites
Discovery of a malaria parasite's internal clock could lead to new treatment strategies.

Breakthrough in malaria research
An international scientific consortium led by the cell biologists Volker Heussler from the University of Bern and Oliver Billker from the UmeƄ University in Sweden has for the first time systematically investigated the genome of the malaria parasite Plasmodium throughout its life cycle in a large-scale experiment.

Scientists close in on malaria vaccine
Scientists have taken another big step forward towards developing a vaccine that's effective against the most severe forms of malaria.

New tool in fight against malaria
Modifying a class of molecules originally developed to treat the skin disease psoriasis could lead to a new malaria drug that is effective against malaria parasites resistant to currently available drugs.

Malaria expert warns of need for malaria drug to treat severe cases in US
The US each year sees more than 1,500 cases of malaria, and currently there is limited access to an intravenously administered (IV) drug needed for the more serious cases.

Monkey malaria breakthrough offers cure for relapsing malaria
A breakthrough in monkey malaria research by two University of Otago scientists could help scientists diagnose and treat a relapsing form of human malaria.

Getting to zero malaria cases in zanzibar
New research led by the Johns Hopkins Center for Communication Programs, Ifakara Health Institute and the Zanzibar Malaria Elimination Program suggests that a better understanding of human behavior at night -- when malaria mosquitoes are biting -- could be key to preventing lingering cases.

Widely used malaria treatment to prevent malaria in pregnant women
A global team of researchers, led by a research team at the Liverpool School of Tropical Medicine (LSTM), are calling for a review of drug-based strategies used to prevent malaria infections in pregnant women, in areas where there is widespread resistance to existing antimalarial medicines.

Protection against Malaria: A matter of balance
A balanced production of pro and anti-inflammatory cytokines at two years of age protects against clinical malaria in early childhood, according to a study led by ISGlobal, an institution supported by ''la Caixa'' Foundation.

The math of malaria
A new mathematical model for malaria shows how competition between parasite strains within a human host reduces the odds of drug resistance developing in a high-transmission setting.

Read More: Malaria News and Malaria Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.